Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reimer

Showing results (111-120 of 153) with videos related to

Pageof 16
Sort By:
Clinical Colorectal Cancer|August 2, 2020
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX TrialStefan Kasper, Johannes Meiler, Heike Knipp, et al.
European Radiology|December 13, 2023
Safe use of contrast media in myasthenia gravis: systematic review and updated European Society of Urogenital Radiology Contrast Media Safety Committee guidelinesRemy W F Geenen, Giles Roditi, Marie-France Bellin, et al.
British Journal of Haematology|November 1, 2018
Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial)Jürgen Krauter, Walter Fiedler, Richard F Schlenk, et al.
European Radiology|October 12, 2023
Waiting times between examinations with intravascularly administered contrast media: a review of contrast media pharmacokinetics and updated ESUR Contrast Media Safety Committee guidelinesAart J van der Molen, Ilona A Dekkers, Remy W F Geenen, et al.
European Journal of Haematology|November 11, 2025
Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 TrialTim Richardson, Elias Mai, Ekaterina Menis, et al.
European Radiology|April 4, 2024
Contrast media for hysterosalpingography: systematic search and review providing new guidelines by the Contrast Media Safety Committee of the European Society of Urogenital RadiologyRemy W F Geenen, Aart J van der Molen, Ilona A Dekkers, et al.
Haematologica|February 13, 2023
General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemiaNicola Gökbuget, Kristina Ihrig, Michael Stadler, et al.
European Radiology|February 17, 2022
Intravenous contrast medium extravasation: systematic review and updated ESUR Contrast Media Safety Committee GuidelinesGiles Roditi, Nadir Khan, Aart J van der Molen, et al.
Cancer Medicine|June 14, 2021
Preinfection laboratory parameters may predict COVID-19 severity in tumor patientsAlexander Kiani, Romina Roesch, Clemens M Wendtner, et al.
European Radiology|March 12, 2026
Safety of positive gastrointestinal contrast media. Updated guidelines by the ESUR Contrast Media Safety CommitteeCarmen Sebastià, Aart J van der Molen, Francisco Vega, et al.
Pageof 16

Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Clinical Colorectal Cancer|August 2, 2020
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX TrialStefan Kasper, Johannes Meiler, Heike Knipp, et al.
European Radiology|December 13, 2023
Safe use of contrast media in myasthenia gravis: systematic review and updated European Society of Urogenital Radiology Contrast Media Safety Committee guidelinesRemy W F Geenen, Giles Roditi, Marie-France Bellin, et al.
British Journal of Haematology|November 1, 2018
Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial)Jürgen Krauter, Walter Fiedler, Richard F Schlenk, et al.
European Radiology|October 12, 2023
Waiting times between examinations with intravascularly administered contrast media: a review of contrast media pharmacokinetics and updated ESUR Contrast Media Safety Committee guidelinesAart J van der Molen, Ilona A Dekkers, Remy W F Geenen, et al.
European Journal of Haematology|November 11, 2025
Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 TrialTim Richardson, Elias Mai, Ekaterina Menis, et al.
European Radiology|April 4, 2024
Contrast media for hysterosalpingography: systematic search and review providing new guidelines by the Contrast Media Safety Committee of the European Society of Urogenital RadiologyRemy W F Geenen, Aart J van der Molen, Ilona A Dekkers, et al.
Haematologica|February 13, 2023
General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemiaNicola Gökbuget, Kristina Ihrig, Michael Stadler, et al.
European Radiology|February 17, 2022
Intravenous contrast medium extravasation: systematic review and updated ESUR Contrast Media Safety Committee GuidelinesGiles Roditi, Nadir Khan, Aart J van der Molen, et al.
Cancer Medicine|June 14, 2021
Preinfection laboratory parameters may predict COVID-19 severity in tumor patientsAlexander Kiani, Romina Roesch, Clemens M Wendtner, et al.
European Radiology|March 12, 2026
Safety of positive gastrointestinal contrast media. Updated guidelines by the ESUR Contrast Media Safety CommitteeCarmen Sebastià, Aart J van der Molen, Francisco Vega, et al.
Pageof 16